Anika Therapeutics Inc. (NASDAQ:ANIK) Stock Quotes and News

Anika Therapeutics Inc. (ANIK) 14.40 0.25

Price Open:	14.18	Day's Range:	0.00000 - 15.07900
Price Close:	14.15	52wk Range:	0.00000 - 17.70
Price Day Change:	0.25	Volume:	64,714
Price % Change:	1.77	Market Cap:	194.5M
Bid:	13.30000	PE Ratio:	15.92
Ask:	15.50000	EPS Diluted:	0.889

Trade ANIK NOW!

The Latest On ANIK

Morning Market Losers 12/5/12 10:55am

Benzinga's Volume Movers 4/9/12 10:22am

Stocks Hitting 52-Week Highs 4/9/12 10:09am

Why Zillow Trumps Facebook in Our Model 3/9/12 2:07pm

Anika Therapeutics Announces U.S. MONOVISC License and Supply Agreement with DePuy Mitek 12/21/11 4:34pm

Anika Therapeutics Appoints Jing-wen Kuo as Chief Scientific Offices 8/18/11 12:45pm

Anika Therapeutics Announces U.S. Distribution Agreement for Advanced Wound Care Product 6/1/11 4:18pm

Top Percentage Gainers And Losers As Of 3:30 p.m. 4/12/2011 (CYH, THC, IDIX, BAC, ANIK, SKH, JPM, UAL, BIOD, SCEI, DGW, CCRT, WMS, EXTR, LFT, SB, HOGS, CAAS, SGI) 4/12/11 3:48pm

Stocks on the Move:(ANIK) New Year High $10.12 3/11/11 11:01am

Anika Therapeutics Appoints Jeffery S. Thompson to its Board 1/20/11 10:08am

Two Stocks Crossing Over Their 50 Day Moving Averages (ANIK, EKB) 11/30/10 2:35pm

Press Releases

Anika Therapeutics Reports First-Quarter 2013 Financial Results 5/1/13 Business Wire

Anika Therapeutics Announces Date of First-Quarter 2013 Financial Results Conference Call 4/5/13 Business Wire

Anika Therapeutics to Present at the Canaccord Genuity Musculoskeletal Conference on March 19 3/13/13 Business Wire

Anika Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results 2/27/13 Business Wire

Anika Therapeutics Announces Date of Fourth-Quarter and Year-End 2012 Financial Results Conference Call 2/14/13 Business Wire

Anika Therapeutics Names Sylvia Cheung as Chief Financial Officer 1/22/13 Business Wire

Anika Therapeutics Announces Monovisc PMA News 12/4/12 Business Wire

Get the latest ANIK stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Anika Therapeutics Inc. stock price.

Partner Headlines

SGEN's Adcetris under FDA Review - Analyst Blog 5/16/13

Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog 5/15/13

Amgen to Set Up JV in China - Analyst Blog 5/14/13

Disappointing 1Q Earnings for IART - Analyst Blog 5/10/13

Wider-than-Expected Loss at Dynavax - Analyst Blog 5/7/13

Zacks #1 Rank Additions for Thursday - Tale of the Tape 5/2/13

WEEKLY CFO SELLS HIGHLIGHT: ANIK, GILD, PETM, NKE, ADBE 3/31/13

Anika Therapeutics Inc. Reports Operating Results (10-Q) 11/8/12

Anika Therapeutics Inc. Reports Operating Results (10-Q) 8/7/12

Vivus Rises Ahead Of FDA Vote On Qnexa Diet Drug 7/16/12

Health Care Sector Wrap 7/2/12